2018
DOI: 10.1136/bcr-2017-223952
|View full text |Cite
|
Sign up to set email alerts
|

Cerebellar degeneration in primary Sjӧgren syndrome

Abstract: Neurological manifestations are reported as a consequence of primary Sjӧgren syndrome (PSS). Any part of the brain and peripheral nervous system can be involved in PSS. However, cerebellar degeneration and atrophy associated with PSS have been rarely reported. Our report describes a 22-year-old woman who presented with cerebellar ataxia, arthritis and arthralgia. Evaluation of her symptoms, autoantibodies and salivary gland pathology was in favour of the diagnosis of Sjögren syndrome. Also, her brain MRI revea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(13 citation statements)
references
References 35 publications
0
10
1
Order By: Relevance
“…The most notable finding in the literature review was the positive rate of autoantibody detection ( Table 1 ). Although anti-Ro/SSA antibodies in the serum were positive in all patients, anti-La/SSB antibodies in the serum were negative in five of the 14 patients [ 7 , 12 , 16 - 18 ]. In addition, our patient 2, who had SjS with PNS involvement but no CNS involvement, was negative for both anti-Ro/SSA and anti-La/SSB antibodies in the CSF.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…The most notable finding in the literature review was the positive rate of autoantibody detection ( Table 1 ). Although anti-Ro/SSA antibodies in the serum were positive in all patients, anti-La/SSB antibodies in the serum were negative in five of the 14 patients [ 7 , 12 , 16 - 18 ]. In addition, our patient 2, who had SjS with PNS involvement but no CNS involvement, was negative for both anti-Ro/SSA and anti-La/SSB antibodies in the CSF.…”
Section: Resultsmentioning
confidence: 98%
“…We found 14 patients with previously reported SjS, including our patient 1, who also had developed cerebellar degeneration [6][7][8][9][10][11][12][13][14][15][16][17][18]. The characteristics of cerebellar degeneration in patients with SjS are provided in Table 1.…”
Section: Characteristics Of Cerebellar Degeneration In Patients With Sjsmentioning
confidence: 99%
“…The most notable nding in this literature review was the positive rate of autoantibody detection (Table). Although anti-Ro/SSA antibodies in the serum were positive in all patients, anti-La/SSB antibodies in the serum were negative in 5 of 14 patients [5,10,[15][16][17]. Additionally, Patient 2 of our study, who had SjS with a peripheral neuropathy but no CNS involvement, was negative for both anti-Ro/SSA and anti-La/SSB antibodies in the CSF.…”
Section: The Characteristics Of Cerebellar Degeneration In Patients Wmentioning
confidence: 48%
“…Nanri K [11] 2011/F/84 / IVIG Kim MJ [12] 2012/F/46 / Pre HCQ Chen YW [13] 2013/F/44 / NP Pre Sharma R [14] 2014/M/64 / NP Pre CTX Farhat E [15] 2016/F/30 / NP Pre CTX Maciel R [16] 2017/F/36 / Pre CTX Heidary M [17] 2018/F/22 / Pre CTX Our case 2020/M/36 / Pre IVIG *Whether the diagnosis of SjS had been made prior to the onset of cerebellar degeneration. Abbreviations: M: male; F: female; NP: not performed; ANA: antinuclear antibody; Pre: prednisolone; IVIG: intravenous immunoglobulin; HCQ: hydroxychloroquine; CTX: cyclophosphamide; R: remission; I: Improvement; S: stable; P: progression.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation